Primecap Management’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1
| Closed | -$13K | – | 294 |
|
|
2018
Q4 | $13K | Sell |
1
-2
| -67% | -$26K | ﹤0.01% | 291 |
|
|
2018
Q3 | $91K | Sell |
3
-21
| -88% | -$637K | ﹤0.01% | 292 |
|
|
2018
Q2 | $1.7M | Hold |
24
| – | – | ﹤0.01% | 276 |
|
|
2018
Q1 | $9.06M | Hold |
24
| – | – | 0.01% | 238 |
|
|
2017
Q4 | $6.3M | Buy |
24
+2
| +9% | +$525K | ﹤0.01% | 245 |
|
|
2017
Q3 | $5.73M | Buy |
22
+1
| +5% | +$260K | ﹤0.01% | 246 |
|
|
2017
Q2 | $6.07M | Buy |
21
+1
| +5% | +$289K | 0.01% | 247 |
|
|
2017
Q1 | $6.48M | Buy |
20
+6
| +43% | +$1.94M | 0.01% | 246 |
|
|
2016
Q4 | $5.72M | Buy |
14
+3
| +27% | +$1.22M | 0.01% | 246 |
|
|
2016
Q3 | $10.1M | Hold |
11
| – | – | 0.01% | 225 |
|
|
2016
Q2 | $8.08M | Buy |
11
+3
| +38% | +$2.2M | 0.01% | 227 |
|
|
2016
Q1 | $6.96M | Buy |
8
+2
| +33% | +$1.74M | 0.01% | 233 |
|
|
2015
Q4 | $5.47M | Buy |
6
+1
| +20% | +$912K | 0.01% | 235 |
|
|
2015
Q3 | $4.44M | Buy |
5
+1
| +25% | +$887K | ﹤0.01% | 246 |
|
|
2015
Q2 | $5.61M | Hold |
4
| – | – | 0.01% | 233 |
|
|
2015
Q1 | $6.28M | Buy |
+4
| New | +$6.28M | 0.01% | 230 |
|